Navigating Imposter Syndrome as a New Derm Resident
June and July mark a major milestone—you’re wrapping up intern year and are finally starting dermatology residency. You’ve survived night shifts, rapid responses, and figuring out how to juggle clinical demands like a pro. Just when you felt like you were getting the hang of things… you’re resetting the clock and diving headfirst into a specialty that sometimes feels like an entirely dif …
June and July mark a major milestone—you’re wrapping up intern year and are finally starting dermatology residency. You’ve survived night shifts, rapid responses, and figuring out how to juggle clinical demands like a pro. Just when you felt like you were getting the hang of things… you’re resetting the clock and diving headfirst into a specialty that sometimes feels like an entirely dif … Continue reading "Navigating Imposter Syndrome as a New Derm Resident"
The July 2025 issue of the Journal of Drugs in Dermatology brings together another outstanding selection of articles, offering cutting-edge insights and real-world strategies across a diverse range of dermatology topics. This month’s editor’s highlights spotlight innovative approaches to photoprotection in melasma and photodamage, emerging non-pharmaceutical solutions for fem … 
Secukinumab is a recombinant human monoclonal immunoglobulin IgG1κ antibody that selectively targets interleukin-17A (IL-17A), a key effector cytokine in the Th17 pathway implicated in the pathogenesis of psoriasis. With its high target specificity, rapid onset, sustained efficacy, and favorable safety profile, secukinumab has become a mainstay in the treatment of psoriasis and other inflammatory … 
A 70-year-old woman with biopsy-confirmed bullous pemphigoid presents with new-onset confusion, hypotension, and leukocytosis two weeks after starting systemic prednisone 60 mg daily. She also reports tremors and blood glucose of 320 mg/dL. What is the next best step in management?
A. Taper corticosteroids and begin doxycycline and … 
A resurgence in the use of isotretinoin is one of the developments changing the way Dr. Neal Bhatia treats acne. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Bhatia, a dermatologist in San Diego. Watch as Dr. Bhatia shares some new developments in the management of patients on isotretinoin. Hear the benefits of a newly marketed triple combination cream. …